230 related articles for article (PubMed ID: 7688786)
1. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells.
Nonoyama S; Hollenbaugh D; Aruffo A; Ledbetter JA; Ochs HD
J Exp Med; 1993 Sep; 178(3):1097-102. PubMed ID: 7688786
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4.
Nonoyama S; Farrington ML; Ochs HD
Clin Immunol Immunopathol; 1994 Sep; 72(3):373-9. PubMed ID: 7520376
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
4. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
Punnonen J; de Vries JE
J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.
Defrance T; Vanbervliet B; Brière F; Durand I; Rousset F; Banchereau J
J Exp Med; 1992 Mar; 175(3):671-82. PubMed ID: 1371300
[TBL] [Abstract][Full Text] [Related]
6. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory role of CD40 in human B cell differentiation.
Splawski JB; Fu SM; Lipsky PE
J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
[TBL] [Abstract][Full Text] [Related]
8. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
9. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
10. Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells.
Ling NR; Brown B; Hardie D
Clin Exp Immunol; 1995 Aug; 101(2):369-75. PubMed ID: 7544253
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel CD2+ human thymic B cell subset.
Punnonen J; de Vries JE
J Immunol; 1993 Jul; 151(1):100-10. PubMed ID: 7686927
[TBL] [Abstract][Full Text] [Related]
12. Activation of thymic B cells by signals of CD40 molecules plus interleukin-10.
Inaba M; Inaba K; Fukuba Y; Mori S; Haruna H; Doi H; Adachi Y; Iwai H; Hosaka N; Hisha H
Eur J Immunol; 1995 May; 25(5):1244-8. PubMed ID: 7539753
[TBL] [Abstract][Full Text] [Related]
13. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
Grabstein KH; Maliszewski CR; Shanebeck K; Sato TA; Spriggs MK; Fanslow WC; Armitage RJ
J Immunol; 1993 Apr; 150(8 Pt 1):3141-7. PubMed ID: 7682232
[TBL] [Abstract][Full Text] [Related]
14. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.
Hokazono Y; Adachi T; Wabl M; Tada N; Amagasa T; Tsubata T
J Immunol; 2003 Aug; 171(4):1835-43. PubMed ID: 12902484
[TBL] [Abstract][Full Text] [Related]
16. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
Farrington M; Grosmaire LS; Nonoyama S; Fischer SH; Hollenbaugh D; Ledbetter JA; Noelle RJ; Aruffo A; Ochs HD
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1099-103. PubMed ID: 7508119
[TBL] [Abstract][Full Text] [Related]
18. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions.
Miyashita T; McIlraith MJ; Grammer AC; Miura Y; Attrep JF; Shimaoka Y; Lipsky PE
J Immunol; 1997 May; 158(10):4620-33. PubMed ID: 9144474
[TBL] [Abstract][Full Text] [Related]
20. CD40 signalling in ileal Peyer's patch B cells: implications for T cell-dependent antigen selection.
Griebel P; Ferrari G
Int Immunol; 1995 Mar; 7(3):369-79. PubMed ID: 7540860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
